AQEMIA Company Overview
Aqemia is a pharmaceutical company utilizing computational chemistry and artificial intelligence to accelerate drug discovery and development. Their innovative approach enables the design of novel molecules with desired properties, optimizing the drug discovery process and reducing time and costs. Aqemia's mission is to revolutionize the pharmaceutical industry and more efficiently bring life-changing medications to patients. Aqemia uses quantum-based physics and AI tools and has become one of the most effective research companies in the world at discovering potential new pharmaceutical drugs for the treatment of a plethora of illnesses.
AQEMIA Valuation History
AQEMIA Stock Price
The stock price of AQEMIA can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming AQEMIA has issued 250 million shares, at the estimated UpMarket valuation of $5.34 million, each share of AQEMIA stock would be worth $0.02.
Buy AQEMIA Stock
If you would like to buy shares in AQEMIA, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss AQEMIA stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, AQEMIA as well.
AQEMIA Management
| Name | Position |
|---|---|
| Maximilien Levesque | CEO |
| Emmanuelle Martiano | Co-Founder |
